Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01593488
What this trial is testing

Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic Leukemia
National Cancer Institute, Naples 31
Testing effectiveness (Phase 2)Study completedNCT01266603
What this trial is testing

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT02866227
What this trial is testing

TOL-463 Phase 2 Study for Vaginitis

Who this might be right for
Bacterial VaginosisVulvovaginal Candidiasis
Toltec Pharmaceuticals, LLC 106
Testing effectiveness (Phase 2)Ended earlyNCT00766142
What this trial is testing

Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPrimary Peritoneal Cavity Cancer
Institut Bergonié 18
Testing effectiveness (Phase 2)UnknownNCT04413942
What this trial is testing

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 99
Testing effectiveness (Phase 2)Looking for participantsNCT05855083
What this trial is testing

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Omeros Corporation 18
Testing effectiveness (Phase 2)Study completedNCT03718091
What this trial is testing

M6620 (VX-970) in Selected Solid Tumors

Who this might be right for
Solid TumorLeiomyosarcomaOsteosarcoma
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02128074
What this trial is testing

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

Who this might be right for
Anemia of Chronic Kidney Disease
Keryx Biopharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT00041990
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687890
What this trial is testing

Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseIgA Nephropathy
Biocity Biopharmaceutics Co., Ltd. 255
Early research (Phase 1)Study completedNCT04771390
What this trial is testing

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 52
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT00083720
What this trial is testing

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Who this might be right for
Colorectal NeoplasmsMetastasesNeoplasm
Eli Lilly and Company 87
Not applicableStudy completedNCT04420260
What this trial is testing

Primary Prevention of Infection by COVID-19 in Workers

Who this might be right for
COVID
Unidad de Investigación Genética Molecular 152
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT02332980
What this trial is testing

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more
Mayo Clinic 65
Testing effectiveness (Phase 2)Ended earlyNCT04938180
What this trial is testing

Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisTGCT+1 more
AmMax Bio, Inc. 4
Large-scale testing (Phase 3)Study completedNCT00638703
What this trial is testing

Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients

Who this might be right for
Primary Hyperoxaluria
OxThera 43
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT07313761
What this trial is testing

A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations

Who this might be right for
Overweight and Obesity
Amgen 349
Next Page